UroGen Pharma Ltd.
URGN
$47.11
$0.801.73%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -31.21% | -28.39% | -49.11% | -49.10% | -34.89% |
| Total Receivables | 351.71% | 182.17% | 62.95% | -13.59% | 12.83% |
| Inventory | 244.96% | 175.64% | 78.43% | 9.84% | -4.22% |
| Prepaid Expenses | 5.98% | 50.43% | 65.88% | -13.74% | -1.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 22.83% | 23.33% | 25.46% | 25.54% | 31.15% |
| Total Current Assets | 19.59% | 0.12% | -32.63% | -42.88% | -29.43% |
|
|
|||||
| Total Current Assets | 19.59% | 0.12% | -32.63% | -42.88% | -29.43% |
| Net Property, Plant & Equipment | 31.83% | 59.03% | 139.98% | 453.25% | 240.93% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 814.01% | 1,302.19% | 597.78% | 1,172.66% | 15.33% |
| Total Assets | 21.02% | 2.45% | -29.84% | -38.71% | -25.95% |
|
|
|||||
| Total Accounts Payable | 14.07% | 18.14% | 11.03% | 85.01% | 63.09% |
| Total Accrued Expenses | 26.45% | 23.11% | 7.48% | 16.62% | 30.32% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 35.34% | 35.50% | 14.71% | 92.48% | 94.47% |
| Total Finance Division Other Current Liabilities | 124.71% | 7.25% | -46.56% | 3.73% | 20.11% |
| Total Other Current Liabilities | 124.71% | 7.25% | -46.56% | 3.73% | 20.11% |
| Total Current Liabilities | 30.22% | 20.56% | 1.02% | 28.84% | 38.94% |
|
|
|||||
| Total Current Liabilities | 30.22% | 20.56% | 1.02% | 28.84% | 38.94% |
| Long-Term Debt | 54.06% | 55.22% | 0.39% | 0.33% | 25.25% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 55.26% | 98.77% | 270.36% | 2,843.87% | 703.06% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.32% | 3.94% | 4.79% | 6.69% | 8.02% |
| Total Liabilities | 27.44% | 28.52% | 3.88% | 8.69% | 20.10% |
|
|
|||||
| Common Stock & APIC | 7.27% | 6.90% | 7.13% | 3.01% | 4.03% |
| Retained Earnings | -10.85% | -15.67% | -19.04% | -21.42% | -20.80% |
| Treasury Stock & Other | -133.33% | -42.86% | -66.07% | -90.25% | 119.35% |
| Total Common Equity | -41.79% | -167.45% | -1,098.16% | -552.31% | -408.03% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -41.79% | -167.45% | -1,098.16% | -552.31% | -408.03% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -41.79% | -167.45% | -1,098.16% | -552.31% | -408.03% |
|
|
|||||